Press release
Fibrin Sealants Market is Projected to Reach US$ 1.92 Billion at a CAGR of 7% by 2033
Fibrin Sealants Market
A fibrin sealant patch is a two-component hemostatic patch made of flexible collagen or cellulose and implanted with fibrinogen and thrombin derived from human plasma. These patches deliver both human fibrinogen and thrombin to the bleeding site, making them effective for hemostasis without relying on the patient's blood having sufficient amounts of fibrinogen.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8182
Key Companies Profiled
Adhesys Medical GmbH
Baxter
Covidien Inc.
CSL Behring
Ethicon
Johnson & Johnson Services, Inc.
Mallinckrodt Pharmaceuticals
Stryker
Takeda Pharmaceutical
Vivostat A/S
Country-wise Analysis
The U.S. currently holds a dominant position in the North American fibrin sealants market due to its advanced healthcare infrastructure, widespread usage of cutting-edge automated analyzers, and a large target patient base.
In 2018, Sysmex Corporation introduced the Automated Blood Coagulation Analyzers CN-6000 and CN-3000, next-generation analyzers in the hemostasis field. Technological advancements have increased accessibility to healthcare services, and the entry of new manufacturers is likely to fuel sales growth in the coming years. The rising prevalence of blood clot-related disorders is also driving demand for fibrin sealants.
According to the U.S. Centers for Disease Control and Prevention (CDC), hemophilia affects one in every 5,617 live male births, with between 30,000 and 33,000 males in the U.S. being hemophilic. Additionally, a person in the United States dies from cardiovascular disease every 34 seconds. These factors are increasing the demand for fibrin sealants in the U.S.
Category-wise Analysis
Throughout the projected period, hospitals are anticipated to hold a significant share of the market. The increasing number of coronary artery bypass grafting and other cardiovascular surgeries performed in hospitals, driven by the presence of advanced healthcare facilities and improved technologies, is expected to boost demand for fibrin sealants.
According to a Yale Medicine article, about 900,000 percutaneous coronary interventions (PCIs) are carried out annually in the U.S. Additionally, there is a steady shift in patient preference from inpatient to outpatient visits, which is predicted to provide specialty clinics with significant growth opportunities during the forecast period.
Read More: https://www.factmr.com/report/fibrin-sealants-market
Competitive Landscape
The fibrin sealants market is highly concentrated, with a few significant competitors controlling the majority of the market share. Baxter and Ethicon (a division of Johnson & Johnson Services, Inc.) are the leading players, with Baxter holding the dominant position in terms of revenue.
Baxter's strong brand recognition, stable client base, global presence, and reliable distribution network contribute to its market leadership. Ethicon is expected to increase its market share over the forecast period due to ongoing product introductions, strategic partnerships, and a focus on market penetration in emerging regions.
For example, Baxter recently presented Tisseel fibrin sealant hemostatic agents with design improvements at the AORN symposium.
Additionally, in May 2019, J&J's Ethicon acquired Takeda's TachoSil Surgical Patch for US$ 400 million, further strengthening its market position.
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8182
Key Segments of Fibrin Sealants Industry Research
By Type :
Liquid
Patches
By Application :
Cardiovascular Surgeries
Orthopedic Surgeries
General Surgeries
Transplant Surgeries
Wound Management
Thoracic Surgeries
Neurosurgeries
Dental Surgeries
Urological Surgeries
Ophthalmic Surgeries
By Technology :
Viral Inactivation
Autologous Donation
Recombinant Production
By End User :
Hospitals
Specialty Clinics
Ambulatory Surgical Centres
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibrin Sealants Market is Projected to Reach US$ 1.92 Billion at a CAGR of 7% by 2033 here
News-ID: 3577894 • Views: โฆ
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L โฆ
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-worldโฆ
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 โฆ
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays aโฆ
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 โฆ
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stableโฆ
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M โฆ
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,โฆ
More Releases for Surgeries
Global Anastomosis Assist Device Market by Type (Reusable, Disposable), By Appli โฆ
Overview of the regional outlook of the Anastomosis Assist Device Market:
The market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa based on region (MEA). The North American continent is further divided into nations like the United States and Canada. Europe is further divided into the United Kingdom, France, Germany, Italy, Spain, Russia, and the Rest of Europe. China, Japan, South Korea, India,โฆ
Anastomosis Assist Device Market Report 2018: Segmentation by Product (Reusable, โฆ
Global Anastomosis Assist Device market research report provides company profile for Medtronic PLC, Sorin Group, Maquet, Guidant Group, Inc., Terumo Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also providesโฆ
Powder-based, Needle-free Injection System Market Report 2018: Segmentation by P โฆ
Global Powder-based, Needle-free Injection System market research report provides company profile for Antares Pharma, Inc., Endo International PLC, Pharmajet, Inc., Inovio Pharmaceuticals, Inc., Medical International Technology, Inc., Injex Pharma AG, National Medical Products, Inc., Valeritas, Inc., European Pharma Group, Penject Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 inโฆ
Powder-based Needle Free Injector Market 2022 : Cardiovascular Surgeries, Genera โฆ
The Global Powder-based Needle Free Injector Market Research Report 2017 renders deep perception of the key regional market status of the Powder-based Needle Free Injector Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on โGlobal Powder-based Needle Free Injector Marketโ is a professional reportโฆ
Endoscopy Devices Market Covering Applications - Urology/Gynecology Surgeries, E โฆ
ALBANY, NY, March 27, 2017 : The endoscopy devices market in Asia Pacific has been classified based on type of device, application, and geography (countries). Major device types include endoscopes, endoscopic operative devices, and visualization systems. Furthermore, endoscope devices include rigid endoscope, flexible endoscope, capsule endoscope, and robot-assisted endoscope. Endoscopic operative devices include energy systems, suction/irrigation systems, access devices, and operative hand instruments. Visualization systems include endoscopic ultrasound devices, standardโฆ
Endoscopy Devices Market,2014-2020: Segmented by gastrointestinal surgeries, uro โฆ
Endoscopy is an invasive medical procedure for the diagnosis, prevention, and treatment of complications in the internal organs. The endoscopy is performed using a device called endoscope. This device is placed into the patient body either through the natural cavities or through incisions. Endoscopy device consists of the camera or the light source at the tip that helps the physicians or medical professionals to analysis the internal organs of interest.โฆ
